Related references
Note: Only part of the references are listed.Germline BRAF Mutations in Noonan, LEOPARD, and Cardiofaciocutaneous Syndromes: Molecular Diversity and Associated Phenotypic Spectrum
Anna Sarkozy et al.
HUMAN MUTATION (2009)
Germline gain-of-function mutations in RAF1 cause Noonan syndrome
M. Abdur Razzaque et al.
NATURE GENETICS (2007)
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
Bhaswati Pandit et al.
NATURE GENETICS (2007)
Control of CNS cell-fate decisions by SHP-2 and its dysregulation in Noonan syndrome
Andree S. Gauthier et al.
NEURON (2007)
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase
Rebecca J. Chan et al.
BLOOD (2007)
Germline gain-of-function mutations in SOS1 cause Noonan syndrome
Amy E. Roberts et al.
NATURE GENETICS (2007)
Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NF kappa B
Jinbo Yang et al.
GENES & DEVELOPMENT (2007)
An unexpected new role of mutant Ras: perturbation of human embryonic development
Christian P. Kratz et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Activation of Tyk2 and Stat3 is required for the apoptotic actions of interferon-β in primary pro-B cells
Ana M. Gamero et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Germline KRAS mutations cause Noonan syndrome
S Schubbert et al.
NATURE GENETICS (2006)
Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease
M Tartaglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease
CP Kratz et al.
BLOOD (2005)
Diverse biochemical properties of Shp2 mutants
H Keilhack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells
S Schubbert et al.
BLOOD (2005)
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
HW Lo et al.
CANCER CELL (2005)
PU.1 expression delineates heterogeneity in primary Th2 cells
HC Chang et al.
IMMUNITY (2005)
Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor
RJ Chan et al.
BLOOD (2005)
Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations
MG Mohi et al.
CANCER CELL (2005)
Roles of Stat3 and ERK in G-CSF signaling
K Kamezaki et al.
STEM CELLS (2005)
Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation
Q Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
ML Loh et al.
BLOOD (2004)
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation
T Araki et al.
NATURE MEDICINE (2004)
Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism
EE Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation
A Fragale et al.
HUMAN MUTATION (2004)
A definitive role of Shp-2 tyrosine phosphatase in mediating embryonic stem cell differentiation and hematopoiesis
RJ Chan et al.
BLOOD (2003)
A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland
EA Kritikou et al.
DEVELOPMENT (2003)
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
M Tartaglia et al.
NATURE GENETICS (2003)
Identification of Shp-2 as a Stat5A phosphatase
Y Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: A critical role of STAT3 in innate immunity
T Welte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
STAT3 is required for FIM-dependent dendritic cell differentiation
Y Laouar et al.
IMMUNITY (2003)
PTPN11 mutations in Noonan syndrome:: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity
M Tartaglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
What does Stat3 do?
DE Levy et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
M Tartaglia et al.
NATURE GENETICS (2001)
The role of STATs in transcriptional control and their impact on cellular function
J Bromberg et al.
ONCOGENE (2000)
Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis
BB Chen et al.
NATURE GENETICS (2000)
Interferon-γ has dual potentials in inhibiting or promoting cell proliferation
H Asao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Dissection of signaling cascades through gp130 in vivo: Reciprocal roles for STAT3-and SHP2-mediated signals in immune responses
T Ohtani et al.
IMMUNITY (2000)
Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity
ZQ Shi et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)